<DOC>
	<DOCNO>NCT01139177</DOCNO>
	<brief_summary>The primary objective study evaluate safety performance SAMBA Stent Delivery System treatment femoropopliteal lesion .</brief_summary>
	<brief_title>SAMBA EU Femoropopliteal Trial</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Screening 1 . Patient must ≥ 21 year age life expectancy &gt; 1 year . 2 . Symptomatic leg ischemia require treatment superficial femoral and/or popliteal artery ( Rutherford category 24 ; claudication , rest pain ) . 3 . Patient must suitable candidate PTA stenting . 4 . Patient willing able return site investigation specify study interval undergo followup requirement . 5 . The patient legal representative provide write informed consent use form review approve EC Clinical Site . PreIntervention 1 . Target lesion ≥ 50 % stenosis demonstrate angiographically . 2 . Lesion length ≤ 15 cm . 3 . Reference vessel diameter 5 6 mm . 4 . Patient least 1 vessel runoff prior treatment . Screening 1 . The subject pregnant become pregnant study condition would preclude xrays . ( Premenopausal woman must negative pregnancy test within 7 day procedure . ) 2 . Patients experience cardiovascular accident ( CVA ) myocardial infarction ( MI ) within 3 month prior procedure . 3 . Subject plan surgical interventional procedure within 30 day implantation procedure SAMBA Stent . 4 . Existing hemorrhagic disease coagulation problem inability take dual antiplatelet therapy . 5 . Contrast allergy correct medication ( e.g . steroid , etc. ) . 6 . Subject medical , social , psychological problem , opinion investigator , preclude receive treatment procedure evaluation pre posttreatment . 7 . Patient currently participate another investigational drug device study . PreIntervention 1 . Uncorrectable severe aortoiliac occlusive disease severe common femoral artery stenosis prevent access limit inflow ( e.g. , stenosis great 50 % ) . 2 . Uncorrectable occlusive disease limit outflow ( e.g. , stenosis great 50 % ) 3 . Patients previous surgery target vessel stent closer 2 cm either edge SAMBA Stent ( ) . 4 . Lack 1 cm healthy vessel proximal proximal target 5 . Lack popliteal reconstitution ( least 2 cm normal distal popliteal ) . 6 . Inability cross lesion guidewire . 7 . More 1 lesion limb require treatment cover continuous stenting . 8 . Unsuccessful balloon predilation ( i.e. , residual stenosis great 30 % ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Peripheral vascular disease - SFA popliteal artery .</keyword>
</DOC>